For example, ZNF132 was shown to be epigenetically silenced via promoter hypermethylation in HNSCC [23,24], esophageal squamous cell carcinoma (ESCC) [20], and lung adenocarcinoma (LUAD) [29]. Here, ZNF132 is linked to head and neck squamous cell carcinoma.